Kathryn E Lewandowski1, Sarah H Sperry2, Mary C Malloy3, Brent P Forester4. 1. Schizophrenia and Bipolar Disorder Program, McLean Hospital, Belmont, MA; Department of Psychiatry, Harvard Medical School, Boston, MA. Electronic address: klewandowski@mclean.harvard.edu. 2. Schizophrenia and Bipolar Disorder Program, McLean Hospital, Belmont, MA. 3. Geriatric Mood Disorders Research Program, McLean Hospital, Belmont, MA. 4. Geriatric Mood Disorders Research Program, McLean Hospital, Belmont, MA; Department of Psychiatry, Harvard Medical School, Boston, MA.
Abstract
OBJECTIVE: Cognitive dysfunction is a core feature of bipolar disorder (BD) in both adult and geriatric patients. However, little is known about whether cognitive functioning declines at a faster rate in patients with BD, and there are conflicting reports regarding the relationship between age and cognitive functioning in this population. This cross-sectional study examined the relationship between age and cognitive functioning in patients with BD. METHODS: Patients with BD I (N = 113) and healthy adults (N = 64) ages 18-87 completed measures of processing speed, attention, executive functioning, verbal fluency, and clinical symptomatology. Groupwise comparisons were used to examine differences between patients and the comparison group and adult and geriatric BD cohorts. A series of linear regressions was conducted to examine the relationship of age and cognitive functioning and clinical variables and cognition. RESULTS: Patients performed significantly worse than the comparison group on all neuropsychological measures. Age was a significant predictor of Trails A scores with older age associated with worse performance. CONCLUSIONS: Older age was associated with poorer performance on Trails A in patients with BD but not healthy adults. These results are suggestive of greater dysfunction in processing speed with older age in patients with BD compared with a healthy comparison group. Because cognitive functioning is associated with community outcomes, these findings suggest a need for treatments targeting cognitive symptoms across the life span. Future research exploring neurobiologic evidence for neurodegenerative processes in BD will pave the way for potential therapeutic interventions.
OBJECTIVE:Cognitive dysfunction is a core feature of bipolar disorder (BD) in both adult and geriatric patients. However, little is known about whether cognitive functioning declines at a faster rate in patients with BD, and there are conflicting reports regarding the relationship between age and cognitive functioning in this population. This cross-sectional study examined the relationship between age and cognitive functioning in patients with BD. METHODS:Patients with BD I (N = 113) and healthy adults (N = 64) ages 18-87 completed measures of processing speed, attention, executive functioning, verbal fluency, and clinical symptomatology. Groupwise comparisons were used to examine differences between patients and the comparison group and adult and geriatric BD cohorts. A series of linear regressions was conducted to examine the relationship of age and cognitive functioning and clinical variables and cognition. RESULTS:Patients performed significantly worse than the comparison group on all neuropsychological measures. Age was a significant predictor of Trails A scores with older age associated with worse performance. CONCLUSIONS: Older age was associated with poorer performance on Trails A in patients with BD but not healthy adults. These results are suggestive of greater dysfunction in processing speed with older age in patients with BD compared with a healthy comparison group. Because cognitive functioning is associated with community outcomes, these findings suggest a need for treatments targeting cognitive symptoms across the life span. Future research exploring neurobiologic evidence for neurodegenerative processes in BD will pave the way for potential therapeutic interventions.
Authors: Lucy J Robinson; Jill M Thompson; Peter Gallagher; Utpal Goswami; Allan H Young; I Nicol Ferrier; P Brian Moore Journal: J Affect Disord Date: 2006-03-06 Impact factor: 4.839
Authors: Katherine E Burdick; Joseph F Goldberg; Martin Harrow; Robert N Faull; Anil K Malhotra Journal: J Nerv Ment Dis Date: 2006-04 Impact factor: 2.254
Authors: Vicente Balanzá-Martínez; Rafael Tabarés-Seisdedos; Gabriel Selva-Vera; Anabel Martínez-Arán; Carla Torrent; José Salazar-Fraile; Carmen Leal-Cercós; Eduard Vieta; Manuel Gómez-Beneyto Journal: Psychother Psychosom Date: 2005 Impact factor: 17.659
Authors: A Martínez-Arán; E Vieta; F Colom; C Torrent; J Sánchez-Moreno; M Reinares; A Benabarre; J M Goikolea; E Brugué; C Daban; M Salamero Journal: Bipolar Disord Date: 2004-06 Impact factor: 6.744
Authors: Ariel G Gildengers; Meryl A Butters; Karen Seligman; Mary McShea; Mark D Miller; Benoit H Mulsant; David J Kupfer; Charles F Reynolds Journal: Am J Psychiatry Date: 2004-04 Impact factor: 18.112
Authors: David C Glahn; Carrie E Bearden; Sibel Cakir; Jennifer A Barrett; Pablo Najt; E Serap Monkul; Natalie Maples; Dawn I Velligan; Jair C Soares Journal: Bipolar Disord Date: 2006-04 Impact factor: 6.744
Authors: Ivan Aprahamian; Rodolfo B Ladeira; Breno S Diniz; Orestes V Forlenza; Paula V Nunes Journal: Am J Geriatr Psychiatry Date: 2013-02-06 Impact factor: 4.105
Authors: Sheena I Dev; Tanya T Nguyen; Benjamin S McKenna; Ashley N Sutherland; Hauke Bartsch; Rebecca J Theilmann; Lisa T Eyler Journal: Am J Geriatr Psychiatry Date: 2017-02-16 Impact factor: 4.105
Authors: Elysha Ringin; David W Dunstan; Roger S McIntyre; Michael Berk; Neville Owen; Susan L Rossell; Tamsyn E Van Rheenen Journal: Neuropsychopharmacology Date: 2022-10-15 Impact factor: 8.294